APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oxycodone Drug Market Outlook and Growth Opportunities 2026

Report ID 174021500430 December 2025216 pages

Choose your research edition.

Industry ResearchOxycodone Drug Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Drug Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Oxycodone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Drug Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Drug Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Oxycodone Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oxycodone Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oxycodone Drug market include Endone, Endone, Hikma Pharmaceuticals USA, Hikma Pharmaceuticals USA, Janssen Pharmaceuticals(Johnson & Johnson), OxyContin, OxyContin, Oxynorm and Oxynorm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oxycodone Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oxycodone Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oxycodone Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oxycodone Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Oxycodone Drug Segment by Company

Endone

Endone

Hikma Pharmaceuticals USA

Hikma Pharmaceuticals USA

Janssen Pharmaceuticals(Johnson & Johnson)

OxyContin

OxyContin

Oxynorm

Oxynorm

Proladone

Proladone

Purdue Pharma L.P

Purdue Pharma L.P

Sanofi-Aventis S.A.

Sanofi-Aventis S.A.

Sun Pharmaceutical Industries Ltd.

Targin

Targin

Pfizer

Pfizer

Sun Pharmaceutical Industries Ltd.

Janssen Pharmaceuticals(Johnson & Johnson)

Oxycodone Drug Segment by Type

Anesthesia

Anesthesia

Others

Pain Management

Pain Management

Others

Oxycodone Drug Segment by Application

Ambulatory Surgical Centers (ASCs)

Ambulatory Surgical Centers (ASCs)

Hospitals & Clinics

Hospitals & Clinics

Oxycodone Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Oxycodone Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oxycodone Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oxycodone Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Oxycodone Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oxycodone Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oxycodone Drug industry.

Chapter 3: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oxycodone Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oxycodone Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oxycodone Drug Industry Trends Table 2. Oxycodone Drug Industry Drivers Table 3. Oxycodone Drug Industry Opportunities and Challenges Table 4. Oxycodone Drug Industry Restraints Table 5. Global Oxycodone Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oxycodone Drug Revenue Share by Company (2021-2026) Table 7. Global Oxycodone Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Oxycodone Drug Sales Volume Share by Company (2021-2026) Table 9. Global Oxycodone Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Oxycodone Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oxycodone Drug Key Company Manufacturing Base & Headquarters Table 12. Global Oxycodone Drug Company, Product Type & Application Table 13. Global Oxycodone Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oxycodone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Anesthesia Table 18. Significant Companies of Anesthesia Table 19. Significant Companies of Others Table 20. Significant Companies of Pain Management Table 21. Significant Companies of Pain Management Table 22. Significant Companies of Others Table 23. Global Oxycodone Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Oxycodone Drug Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Oxycodone Drug Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Oxycodone Drug Sales Volume Share by Type (2021-2026) Table 27. Global Oxycodone Drug Sales Volume Share by Type (2027-2032) Table 28. Global Oxycodone Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Oxycodone Drug Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Oxycodone Drug Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Oxycodone Drug Sales Value Share by Type (2021-2026) Table 32. Global Oxycodone Drug Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Ambulatory Surgical Centers (ASCs) Table 34. Significant Companies of Ambulatory Surgical Centers (ASCs) Table 35. Significant Companies of Hospitals & Clinics Table 36. Significant Companies of Hospitals & Clinics Table 37. Global Oxycodone Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Oxycodone Drug Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Oxycodone Drug Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Oxycodone Drug Sales Volume Share by Application (2021-2026) Table 41. Global Oxycodone Drug Sales Volume Share by Application (2027-2032) Table 42. Global Oxycodone Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Oxycodone Drug Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Oxycodone Drug Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Oxycodone Drug Sales Value Share by Application (2021-2026) Table 46. Global Oxycodone Drug Sales Value Share by Application (2027-2032) Table 47. Global Oxycodone Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Oxycodone Drug Sales by Region (2021-2026) & (K Units) Table 49. Global Oxycodone Drug Sales Market Share by Region (2021-2026) Table 50. Global Oxycodone Drug Sales by Region (2027-2032) & (K Units) Table 51. Global Oxycodone Drug Sales Market Share by Region (2027-2032) Table 52. Global Oxycodone Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Oxycodone Drug Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Oxycodone Drug Sales Value Share by Region (2021-2026) Table 55. Global Oxycodone Drug Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Oxycodone Drug Sales Value Share by Region (2027-2032) Table 57. Global Oxycodone Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Oxycodone Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Oxycodone Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Oxycodone Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 62. Global Oxycodone Drug Sales Market Share by Country (2021-2026) Table 63. Global Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 64. Global Oxycodone Drug Sales Market Share by Country (2027-2032) Table 65. Global Oxycodone Drug Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Oxycodone Drug Sales Value Market Share by Country (2021-2026) Table 67. Global Oxycodone Drug Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Oxycodone Drug Sales Value Market Share by Country (2027-2032) Table 69. Endone Company Information Table 70. Endone Business Overview Table 71. Endone Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Endone Oxycodone Drug Product Portfolio Table 73. Endone Recent Development Table 74. Endone Company Information Table 75. Endone Business Overview Table 76. Endone Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Endone Oxycodone Drug Product Portfolio Table 78. Endone Recent Development Table 79. Hikma Pharmaceuticals USA Company Information Table 80. Hikma Pharmaceuticals USA Business Overview Table 81. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 83. Hikma Pharmaceuticals USA Recent Development Table 84. Hikma Pharmaceuticals USA Company Information Table 85. Hikma Pharmaceuticals USA Business Overview Table 86. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 88. Hikma Pharmaceuticals USA Recent Development Table 89. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 90. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 91. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 93. Janssen Pharmaceuticals(Johnson & Johnson) Recent Development Table 94. OxyContin Company Information Table 95. OxyContin Business Overview Table 96. OxyContin Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. OxyContin Oxycodone Drug Product Portfolio Table 98. OxyContin Recent Development Table 99. OxyContin Company Information Table 100. OxyContin Business Overview Table 101. OxyContin Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. OxyContin Oxycodone Drug Product Portfolio Table 103. OxyContin Recent Development Table 104. Oxynorm Company Information Table 105. Oxynorm Business Overview Table 106. Oxynorm Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Oxynorm Oxycodone Drug Product Portfolio Table 108. Oxynorm Recent Development Table 109. Oxynorm Company Information Table 110. Oxynorm Business Overview Table 111. Oxynorm Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Oxynorm Oxycodone Drug Product Portfolio Table 113. Oxynorm Recent Development Table 114. Proladone Company Information Table 115. Proladone Business Overview Table 116. Proladone Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Proladone Oxycodone Drug Product Portfolio Table 118. Proladone Recent Development Table 119. Proladone Company Information Table 120. Proladone Business Overview Table 121. Proladone Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Proladone Oxycodone Drug Product Portfolio Table 123. Proladone Recent Development Table 124. Purdue Pharma L.P Company Information Table 125. Purdue Pharma L.P Business Overview Table 126. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 128. Purdue Pharma L.P Recent Development Table 129. Purdue Pharma L.P Company Information Table 130. Purdue Pharma L.P Business Overview Table 131. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 133. Purdue Pharma L.P Recent Development Table 134. Sanofi-Aventis S.A. Company Information Table 135. Sanofi-Aventis S.A. Business Overview Table 136. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 138. Sanofi-Aventis S.A. Recent Development Table 139. Sanofi-Aventis S.A. Company Information Table 140. Sanofi-Aventis S.A. Business Overview Table 141. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 143. Sanofi-Aventis S.A. Recent Development Table 144. Sun Pharmaceutical Industries Ltd. Company Information Table 145. Sun Pharmaceutical Industries Ltd. Business Overview Table 146. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 148. Sun Pharmaceutical Industries Ltd. Recent Development Table 149. Targin Company Information Table 150. Targin Business Overview Table 151. Targin Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Targin Oxycodone Drug Product Portfolio Table 153. Targin Recent Development Table 154. Targin Company Information Table 155. Targin Business Overview Table 156. Targin Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Targin Oxycodone Drug Product Portfolio Table 158. Targin Recent Development Table 159. Pfizer Company Information Table 160. Pfizer Business Overview Table 161. Pfizer Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Pfizer Oxycodone Drug Product Portfolio Table 163. Pfizer Recent Development Table 164. Pfizer Company Information Table 165. Pfizer Business Overview Table 166. Pfizer Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Pfizer Oxycodone Drug Product Portfolio Table 168. Pfizer Recent Development Table 169. Sun Pharmaceutical Industries Ltd. Company Information Table 170. Sun Pharmaceutical Industries Ltd. Business Overview Table 171. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 173. Sun Pharmaceutical Industries Ltd. Recent Development Table 174. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 175. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 176. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 178. Janssen Pharmaceuticals(Johnson & Johnson) Recent Development Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Oxycodone Drug Distributors List Table 182. Oxycodone Drug Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Oxycodone Drug Product Image Figure 2. Global Oxycodone Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oxycodone Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oxycodone Drug Sales (2021-2032) & (K Units) Figure 5. Global Oxycodone Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Oxycodone Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Anesthesia Image Figure 10. Anesthesia Image Figure 11. Others Image Figure 12. Pain Management Image Figure 13. Pain Management Image Figure 14. Others Image Figure 15. Global Oxycodone Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Oxycodone Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Oxycodone Drug Sales Volume Share by Type (2021-2032) Figure 18. Global Oxycodone Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Oxycodone Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Oxycodone Drug Sales Value Share by Type (2021-2032) Figure 21. Ambulatory Surgical Centers (ASCs) Image Figure 22. Ambulatory Surgical Centers (ASCs) Image Figure 23. Hospitals & Clinics Image Figure 24. Hospitals & Clinics Image Figure 25. Global Oxycodone Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Oxycodone Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Oxycodone Drug Sales Volume Share by Application (2021-2032) Figure 28. Global Oxycodone Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Oxycodone Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Oxycodone Drug Sales Value Share by Application (2021-2032) Figure 31. Global Oxycodone Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Oxycodone Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Oxycodone Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Oxycodone Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Oxycodone Drug Sales Value (2021-2032) & (US$ Million) Figure 36. North America Oxycodone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Oxycodone Drug Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Oxycodone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Oxycodone Drug Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Oxycodone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Oxycodone Drug Sales Value (2021-2032) & (US$ Million) Figure 42. South America Oxycodone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Oxycodone Drug Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Oxycodone Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Oxycodone Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Oxycodone Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Oxycodone Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Oxycodone Drug Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Oxycodone Drug Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Anesthesia
  • Anesthesia
  • Others
  • Pain Management
  • Pain Management
  • Others
Applications
  • Ambulatory Surgical Centers (ASCs)
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals & Clinics
  • Hospitals & Clinics
Companies covered
  • Endone
  • Endone
  • Hikma Pharmaceuticals USA
  • Hikma Pharmaceuticals USA
  • Janssen Pharmaceuticals(Johnson & Johnson)
  • OxyContin
  • OxyContin
  • Oxynorm
  • Oxynorm
  • Proladone
  • Proladone
  • Purdue Pharma L.P
  • Purdue Pharma L.P
  • Sanofi-Aventis S.A.
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Targin
  • Targin
  • Pfizer
  • Pfizer
  • Sun Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals(Johnson & Johnson)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oxycodone Drug Sales Value (2021-2032)
  4. 1.2.2 Global Oxycodone Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Oxycodone Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oxycodone Drug Market Dynamics
  1. 2.1 Oxycodone Drug Industry Trends
  2. 2.2 Oxycodone Drug Industry Drivers
  3. 2.3 Oxycodone Drug Industry Opportunities and Challenges
  4. 2.4 Oxycodone Drug Industry Restraints
3 Oxycodone Drug Market by Company
  1. 3.1 Global Oxycodone Drug Company Revenue Ranking in 2025
  2. 3.2 Global Oxycodone Drug Revenue by Company (2021-2026)
  3. 3.3 Global Oxycodone Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Oxycodone Drug Average Price by Company (2021-2026)
  5. 3.5 Global Oxycodone Drug Company Ranking (2024-2026)
  6. 3.6 Global Oxycodone Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Oxycodone Drug Company Product Type and Application
  8. 3.8 Global Oxycodone Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oxycodone Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oxycodone Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oxycodone Drug Market by Type
  1. 4.1 Oxycodone Drug Type Introduction
  2. 4.1.1 Anesthesia
  3. 4.1.2 Anesthesia
  4. 4.1.3 Others
  5. 4.1.4 Pain Management
  6. 4.1.5 Pain Management
  7. 4.1.6 Others
  8. 4.2 Global Oxycodone Drug Sales Volume by Type
  9. 4.2.1 Global Oxycodone Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Oxycodone Drug Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Oxycodone Drug Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Oxycodone Drug Sales Value by Type
  13. 4.3.1 Global Oxycodone Drug Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Oxycodone Drug Sales Value by Type (2021-2032)
  15. 4.3.3 Global Oxycodone Drug Sales Value Share by Type (2021-2032)
5 Oxycodone Drug Market by Application
  1. 5.1 Oxycodone Drug Application Introduction
  2. 5.1.1 Ambulatory Surgical Centers (ASCs)
  3. 5.1.2 Ambulatory Surgical Centers (ASCs)
  4. 5.1.3 Hospitals & Clinics
  5. 5.1.4 Hospitals & Clinics
  6. 5.2 Global Oxycodone Drug Sales Volume by Application
  7. 5.2.1 Global Oxycodone Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oxycodone Drug Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Oxycodone Drug Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Oxycodone Drug Sales Value by Application
  11. 5.3.1 Global Oxycodone Drug Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Oxycodone Drug Sales Value by Application (2021-2032)
  13. 5.3.3 Global Oxycodone Drug Sales Value Share by Application (2021-2032)
6 Oxycodone Drug Regional Sales and Value Analysis
  1. 6.1 Global Oxycodone Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oxycodone Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Oxycodone Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Oxycodone Drug Sales by Region (2027-2032)
  5. 6.3 Global Oxycodone Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oxycodone Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oxycodone Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oxycodone Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Oxycodone Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oxycodone Drug Sales Value (2021-2032)
  12. 6.6.2 North America Oxycodone Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oxycodone Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Oxycodone Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oxycodone Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oxycodone Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oxycodone Drug Sales Value (2021-2032)
  21. 6.9.2 South America Oxycodone Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oxycodone Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oxycodone Drug Sales Value Share by Country, 2025 VS 2032
7 Oxycodone Drug Country-level Sales and Value Analysis
  1. 7.1 Global Oxycodone Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oxycodone Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oxycodone Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Oxycodone Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Oxycodone Drug Sales by Country (2027-2032)
  6. 7.4 Global Oxycodone Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oxycodone Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oxycodone Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oxycodone Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oxycodone Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oxycodone Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oxycodone Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oxycodone Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oxycodone Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oxycodone Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oxycodone Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oxycodone Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oxycodone Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oxycodone Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oxycodone Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oxycodone Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oxycodone Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oxycodone Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oxycodone Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oxycodone Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oxycodone Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oxycodone Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oxycodone Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oxycodone Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oxycodone Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oxycodone Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oxycodone Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oxycodone Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oxycodone Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oxycodone Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oxycodone Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oxycodone Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oxycodone Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Endone
  2. 8.1.1 Endone Company Information
  3. 8.1.2 Endone Business Overview
  4. 8.1.3 Endone Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Endone Oxycodone Drug Product Portfolio
  6. 8.1.5 Endone Recent Developments
  7. 8.2 Endone
  8. 8.2.1 Endone Company Information
  9. 8.2.2 Endone Business Overview
  10. 8.2.3 Endone Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Endone Oxycodone Drug Product Portfolio
  12. 8.2.5 Endone Recent Developments
  13. 8.3 Hikma Pharmaceuticals USA
  14. 8.3.1 Hikma Pharmaceuticals USA Company Information
  15. 8.3.2 Hikma Pharmaceuticals USA Business Overview
  16. 8.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  18. 8.3.5 Hikma Pharmaceuticals USA Recent Developments
  19. 8.4 Hikma Pharmaceuticals USA
  20. 8.4.1 Hikma Pharmaceuticals USA Company Information
  21. 8.4.2 Hikma Pharmaceuticals USA Business Overview
  22. 8.4.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  24. 8.4.5 Hikma Pharmaceuticals USA Recent Developments
  25. 8.5 Janssen Pharmaceuticals(Johnson & Johnson)
  26. 8.5.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  27. 8.5.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  28. 8.5.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  30. 8.5.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
  31. 8.6 OxyContin
  32. 8.6.1 OxyContin Company Information
  33. 8.6.2 OxyContin Business Overview
  34. 8.6.3 OxyContin Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 OxyContin Oxycodone Drug Product Portfolio
  36. 8.6.5 OxyContin Recent Developments
  37. 8.7 OxyContin
  38. 8.7.1 OxyContin Company Information
  39. 8.7.2 OxyContin Business Overview
  40. 8.7.3 OxyContin Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 OxyContin Oxycodone Drug Product Portfolio
  42. 8.7.5 OxyContin Recent Developments
  43. 8.8 Oxynorm
  44. 8.8.1 Oxynorm Company Information
  45. 8.8.2 Oxynorm Business Overview
  46. 8.8.3 Oxynorm Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Oxynorm Oxycodone Drug Product Portfolio
  48. 8.8.5 Oxynorm Recent Developments
  49. 8.9 Oxynorm
  50. 8.9.1 Oxynorm Company Information
  51. 8.9.2 Oxynorm Business Overview
  52. 8.9.3 Oxynorm Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Oxynorm Oxycodone Drug Product Portfolio
  54. 8.9.5 Oxynorm Recent Developments
  55. 8.10 Proladone
  56. 8.10.1 Proladone Company Information
  57. 8.10.2 Proladone Business Overview
  58. 8.10.3 Proladone Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Proladone Oxycodone Drug Product Portfolio
  60. 8.10.5 Proladone Recent Developments
  61. 8.11 Proladone
  62. 8.11.1 Proladone Company Information
  63. 8.11.2 Proladone Business Overview
  64. 8.11.3 Proladone Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Proladone Oxycodone Drug Product Portfolio
  66. 8.11.5 Proladone Recent Developments
  67. 8.12 Purdue Pharma L.P
  68. 8.12.1 Purdue Pharma L.P Company Information
  69. 8.12.2 Purdue Pharma L.P Business Overview
  70. 8.12.3 Purdue Pharma L.P Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  72. 8.12.5 Purdue Pharma L.P Recent Developments
  73. 8.13 Purdue Pharma L.P
  74. 8.13.1 Purdue Pharma L.P Company Information
  75. 8.13.2 Purdue Pharma L.P Business Overview
  76. 8.13.3 Purdue Pharma L.P Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  78. 8.13.5 Purdue Pharma L.P Recent Developments
  79. 8.14 Sanofi-Aventis S.A.
  80. 8.14.1 Sanofi-Aventis S.A. Company Information
  81. 8.14.2 Sanofi-Aventis S.A. Business Overview
  82. 8.14.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  84. 8.14.5 Sanofi-Aventis S.A. Recent Developments
  85. 8.15 Sanofi-Aventis S.A.
  86. 8.15.1 Sanofi-Aventis S.A. Company Information
  87. 8.15.2 Sanofi-Aventis S.A. Business Overview
  88. 8.15.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  90. 8.15.5 Sanofi-Aventis S.A. Recent Developments
  91. 8.16 Sun Pharmaceutical Industries Ltd.
  92. 8.16.1 Sun Pharmaceutical Industries Ltd. Company Information
  93. 8.16.2 Sun Pharmaceutical Industries Ltd. Business Overview
  94. 8.16.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  96. 8.16.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  97. 8.17 Targin
  98. 8.17.1 Targin Company Information
  99. 8.17.2 Targin Business Overview
  100. 8.17.3 Targin Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Targin Oxycodone Drug Product Portfolio
  102. 8.17.5 Targin Recent Developments
  103. 8.18 Targin
  104. 8.18.1 Targin Company Information
  105. 8.18.2 Targin Business Overview
  106. 8.18.3 Targin Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Targin Oxycodone Drug Product Portfolio
  108. 8.18.5 Targin Recent Developments
  109. 8.19 Pfizer
  110. 8.19.1 Pfizer Company Information
  111. 8.19.2 Pfizer Business Overview
  112. 8.19.3 Pfizer Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Pfizer Oxycodone Drug Product Portfolio
  114. 8.19.5 Pfizer Recent Developments
  115. 8.20 Pfizer
  116. 8.20.1 Pfizer Company Information
  117. 8.20.2 Pfizer Business Overview
  118. 8.20.3 Pfizer Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Pfizer Oxycodone Drug Product Portfolio
  120. 8.20.5 Pfizer Recent Developments
  121. 8.21 Sun Pharmaceutical Industries Ltd.
  122. 8.21.1 Sun Pharmaceutical Industries Ltd. Company Information
  123. 8.21.2 Sun Pharmaceutical Industries Ltd. Business Overview
  124. 8.21.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  126. 8.21.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  127. 8.22 Janssen Pharmaceuticals(Johnson & Johnson)
  128. 8.22.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  129. 8.22.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  130. 8.22.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  132. 8.22.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oxycodone Drug Value Chain Analysis
  2. 9.1.1 Oxycodone Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oxycodone Drug Sales Mode & Process
  6. 9.2 Oxycodone Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oxycodone Drug Distributors
  9. 9.2.3 Oxycodone Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst